Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 1, Pages 80-86
Publisher
Springer Nature
Online
2012-05-16
DOI
10.1038/clpt.2011.369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Active Safety Monitoring of New Medical Products Using Electronic Healthcare Data
- (2012) Joshua J. Gagne et al. EPIDEMIOLOGY
- Design considerations in an active medical product safety monitoring system
- (2012) Joshua J. Gagne et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
- (2011) S Schneeweiss et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Commentary: What Can We Really Learn From Observational Studies?
- (2011) David Madigan et al. EPIDEMIOLOGY
- Developing the Sentinel System — A National Resource for Evidence Development
- (2011) Rachel E. Behrman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics
- (2010) Jeremy A. Rassen et al. MEDICAL CARE
- Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins
- (2010) Luis A. García Rodríguez et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases
- (2010) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- The New Sentinel Network — Improving the Evidence of Medical-Product Safety
- (2009) Richard Platt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing Drug-Risk Information — What to Do with All Those New Numbers
- (2009) Jerry Avorn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Hepatotoxicity Associated with the Use of Telithromycin: A Signal Detection Using Data Mining Algorithms
- (2008) Yan Chen et al. ANNALS OF PHARMACOTHERAPY
- Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases
- (2008) Allen D. Brinker et al. HEPATOLOGY
- The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases
- (2008) Luis Alberto García-Rodríguez et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care
- (2008) Luis Alberto García-Rodríguez et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More